| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 15801915 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 445 journal articles in the PubMed database | Email to a friend | | |
| Bour B, Staub JL, Chousterman M, et al.
Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2005 Apr 1; 21(7):805-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pace F, Annese V, Prada A, et al.
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. [Journal Article, Randomized Controlled Trial]
Dig Liver Dis 2005 Oct; 37(10):741-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Robinson M, Fitzgerald S, Hegedus R, et al.
Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. [Clinical Trial, Journal Article, Multicenter Study]
Aliment Pharmacol Ther 2002 Mar; 16(3):445-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Thjodleifsson B, Rindi G, Fiocca R, et al.
A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2003 Feb; 17(3):343-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bytzer P, Blum A, De Herdt D, et al.
Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2004 Jul 15; 20(2):181-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Caos A, Breiter J, Perdomo C, et al.
Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2005 Aug 1; 22(3):193-202.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pace F, Negrini C, Wiklund I, et al.
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2005 Aug 15; 22(4):349-56.
Abstract | Full Citation | Find Related Articles | | Holtmann G, Bytzer P, Metz M, et al.
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Aliment Pharmacol Ther 2002 Mar; 16(3):479-85.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dickman R, Emmons S, Cui H, et al.
The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. [Journal Article]
Aliment Pharmacol Ther 2005 Sep 15; 22(6):547-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
